Lallemand's Probiokid has been approved by ANVISA for use by infants. This development may allow the company to expand its presence in the Brazilian market. However, it is unclear if this approval is related to other recent regulatory developments involving Lallemand, such as a new Canadian health claim or a European license for a different product.